Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul.
Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea.
J Clin Gastroenterol. 2020 Sep;54(8):720-724. doi: 10.1097/MCG.0000000000001283.
The study aimed to compare the level and characteristics of disease-related knowledge of patients with inflammatory bowel disease (IBD) between the West and the East using an international version of a questionnaire regarding knowledge of inflammatory bowel disease (IBD-KNOW).
The authors recently developed a new questionnaire regarding IBD-KNOW, which showed excellent test characteristics in Korea.
The IBD-KNOW questionnaire was administered to 100 patients with IBD from tertiary referral hospitals in the United States and Korea. Scores were calculated and compared between US and Korean patients, and factors associated with high scores were analyzed.
A total of 196 (100 US and 96 Korean) patients with IBD completed the questionnaires. Analysis of the baseline characteristics revealed that male sex, smoking status, disease duration, history of IBD-related operations, family history of IBD, and use of corticosteroids or biologics were significantly different between US and Korean patients. The mean IBD-KNOW score was higher in US patients than in Korean patients (14.8 vs. 11.3; P<0.001). Multivariate analyses showed that a high IBD-KNOW score (top 25%) was associated with a positive family history of IBD (odds ratio, 2.90; P=0.025) in US patients with IBD and with the use of biologics (odds ratio, 3.65; P=0.008) in Korean patients with IBD.
The IBD-KNOW questionnaire, an updated assessment tool of IBD-related knowledge, is simple, reliable, and available in various patient populations. IBD-KNOW can be used to identify the factors affecting the level of IBD-related knowledge to improve the quality of care in patients with IBD through a personalized approach.
本研究旨在使用一种关于炎症性肠病（IBD）知识的国际问卷（IBD-KNOW），比较东西方炎症性肠病（IBD）患者的疾病相关知识水平和特征。
作者最近开发了一种新的 IBD-KNOW 问卷，该问卷在韩国表现出了优异的测试特征。
IBD-KNOW 问卷在来自美国和韩国三级转诊医院的 100 名 IBD 患者中进行了管理。计算了美国和韩国患者的分数并进行了比较，并分析了与高分相关的因素。
共有 196 名（100 名美国和 96 名韩国）IBD 患者完成了问卷。对基线特征的分析表明，男性、吸烟状况、疾病持续时间、IBD 相关手术史、IBD 家族史和皮质类固醇或生物制剂的使用在美韩患者之间存在显著差异。美国患者的 IBD-KNOW 评分高于韩国患者（14.8 对 11.3；P<0.001）。多变量分析显示，IBD-KNOW 评分高（前 25%）与美国 IBD 患者的 IBD 阳性家族史（优势比，2.90；P=0.025）和韩国 IBD 患者的生物制剂使用（优势比，3.65；P=0.008）相关。
IBD-KNOW 问卷是一种更新的 IBD 相关知识评估工具，简单、可靠，适用于各种患者群体。IBD-KNOW 可用于识别影响 IBD 相关知识水平的因素，通过个性化方法改善 IBD 患者的护理质量。
